Cargando…
A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X
Background:Activated factor X (FXa) is a vitamin K-dependent serine protease that plays a pivotal role in blood coagulation by converting prothrombin to thrombin. There are no reports of humans with complete deficiency of FX, and knockout of murine F10 is embryonic or perinatal lethal. Objective:We...
Autores principales: | TAI, S J, HERZOG, R W, MARGARITIS, P, ARRUDA, V R, CHU, K, GOLDEN, J A, LABOSKY, P A, HIGH, K A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2471867/ https://www.ncbi.nlm.nih.gov/pubmed/18036190 http://dx.doi.org/10.1111/j.1538-7836.2008.02849.x |
Ejemplares similares
-
An engineered U1 small nuclear RNA rescues splicing-defective coagulation F7 gene expression in mice
por: Balestra, D, et al.
Publicado: (2014) -
Four‐factor prothrombin complex concentrate reverses apixaban‐associated bleeding in a rabbit model of acute hemorrhage
por: Herzog, E., et al.
Publicado: (2015) -
Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A
por: Nguyen, G. N., et al.
Publicado: (2016) -
The role of β‐barrels 1 and 2 in the enzymatic activity of factor XIII A‐subunit
por: Hethershaw, E. L., et al.
Publicado: (2018) -
Assessment of the protein interaction between coagulation factor XII and corn trypsin inhibitor by molecular docking and biochemical validation
por: Hamad, B. K., et al.
Publicado: (2017)